Susan A. Knudson
2018 - Pfenex
In 2018, Susan A. Knudson earned a total compensation of $775.2K as Former Chief Financial Officer at Pfenex.
Compensation breakdown
| Non-Equity Incentive Plan | $113,190 |
|---|---|
| Option Awards | $359,923 |
| Salary | $302,077 |
| Total | $775,190 |
Knudson received $359.9K in option awards, accounting for 46% of the total pay in 2018.
Knudson also received $113.2K in non-equity incentive plan and $302.1K in salary.
Rankings
In 2018, Susan A. Knudson's compensation ranked 10,325th out of 14,244 executives tracked by ExecPay. In other words, Knudson earned more than 27.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,325 out of 14,244 | 28th |
Division Manufacturing | 4,162 out of 5,759 | 28th |
Major group Chemicals And Allied Products | 1,564 out of 2,122 | 26th |
Industry group Drugs | 1,319 out of 1,811 | 27th |
Industry Pharmaceutical Preparations | 1,014 out of 1,385 | 27th |
Source: SEC filing on April 1, 2020.
Knudson's colleagues
We found three more compensation records of executives who worked with Susan A. Knudson at Pfenex in 2018.
News
Conatus Pharmaceuticals CFO Susan Knudson's 2022 pay jumps 26% to $681K
May 1, 2023
Conatus Pharmaceuticals CEO Steven Mento's 2020 pay slips 5% to $1.3M
April 15, 2021
Pfenex CEO Evert Schimmelpennink's 2019 pay rises 11% to $1.8M
April 1, 2020
Neothetics CEO Saundra Pelletier's 2018 pay jumps 401% to $8.3M
April 24, 2019
Pfenex CEO Evert Schimmelpennink's 2018 pay jumps 47% to $1.6M
April 4, 2019